Current Insights On The Multidisciplinary Treatment Of Necrotizing Fasciitis
Establishing the diagnosis can be challenging. Clinical findings may include swelling, pain, erythema, induration, crepitation, sloughing off of the skin, or a blistering and purulent collection. Initially, the diagnosis is a clinical one, which one can supplement with imaging (X-ray, magnetic resonance imaging, computed tomography, etc.). Physicians need to ensure immediate and aggressive treatment as necrotizing fasciitis causes rapid tissue destruction.
A Closer Look At The Patient
A 54-year-old male patient with insulin-dependent diabetes presented to the emergency room after his wife found him slumped in his car. He reported that he had generalized weakness and shortness of breath for the past week. The patient recently noticed his great toe was turning black. In addition, during his first hour in the emergency room, erythema spread across the dorsum of the foot and his pain increased to a level of 10 of 10.
His past medical history included diabetes mellitus, hypertension and hyperlipidemia. The patient’s medications prior to hospital admission included Aleve, Centrum, Humalog insulin (Eli Lilly), gabapentin (Neurontin, Pfizer), Quinapril (Accupril, Pfizer), citalopram (Celexa, Forest Laboratories) and hydrocodone/acetaminophen as needed.
In the ER, the patient appeared mildly toxic. His temperature was 36.8ºC, pulse was 96 and respiratory rate was 12. There was significant edema throughout the foot and the right great toe was black in color (figure 1). The patient’s pain was at a level of 10 and palpation for pulses was impossible due to this pain level.
The diagnostic data included a white blood cell count of 24.5, an erythrocyte sedimentation rate of 97, a high sensitivity C-reactive protein of 287.02 and glucose of 57. X-rays revealed small collections of air surrounding the great toe extending into the midfoot (figure 2).
The patient went directly to the operating room where I amputated the great toe and first metatarsal head, debrided the first interspace and expressed all purulent material. I packed the surgical area and left it open. I admitted the patient to the hospital on intravenous piperacillin/tazobactam (Zosyn, Pfizer) and vancomycin.
The patient’s symptoms responded rapidly to surgery. His pain level dropped to a 5 of 10 within 24 hours and all signs of sepsis resolved. Two days after surgery, I removed the packing and he started negative pressure wound therapy (NPWT) with instillation using Dakin’s solution. Instillation therapy delivers and removes topical solutions to an infected wound at controlled times and also provides standard negative pressure (figure 3).
The NPWT with instillation therapy continued for one week. The patient then went back to the OR for further debridement and partial closure of the amputation site (figure 4). He was discharged to home on IV ceftriaxone and traditional Vacuum Assisted Closure (VAC therapy, KCI) therapy. The patient followed an uneventful postoperative course. I discontinued VAC therapy after two weeks (figure 5) and proceeded with traditional wound care and subsequent applications of Apilgraf (Organogenesis) (figure 6).